Our Pricing

Semaglutide Injection UK Pharmacy Supply

Published on: June 03, 2026

Finding a trusted semaglutide injection UK pharmacy is essential for safe, effective weight management. At Cured Pharmacy (GPhC 9012511), we supply genuine UK-licensed semaglutide injections including Wegovy, with transparent pricing from £79.00, free clinical consultations under 3 minutes, and discreet next-day delivery across the UK.

How Semaglutide Injection Works for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone in your body. It works by slowing gastric emptying, reducing appetite signals in the brain, and improving blood sugar regulation — three mechanisms that together support significant weight reduction when combined with dietary changes [1].

In the landmark STEP 1 clinical trial, participants using semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represented one of the most substantial weight loss outcomes seen in pharmaceutical trials at the time. Importantly, 86.4% of participants achieved at least 5% weight loss, and nearly one-third lost more than 20% of their starting weight [1].

The medication is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm. Dosing follows a gradual escalation schedule over 16-20 weeks to minimise gastrointestinal side effects whilst your body adjusts to the medication [2]. Our UK prescribers determine the appropriate starting dose and titration schedule based on your individual medical history and tolerance.

Semaglutide Injection UK Pharmacy: What Makes Cured Different

As a GPhC-registered online pharmacy (9012511), we're held to the same rigorous standards as high-street pharmacies. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees every prescription dispensed, ensuring you receive genuine UK-licensed medications that meet MHRA safety standards.

Unlike some online providers, we display transparent upfront pricing before you begin your consultation — no hidden fees or surprise charges at checkout. Our clinical team completes your free assessment in under 3 minutes, and if approved, your medication is dispensed and dispatched the same day for discreet next-day delivery.

We supply only authentic semaglutide products licensed for use in the UK. Every pen is sourced directly from UK-authorised wholesalers and stored in temperature-controlled pharmaceutical facilities to maintain product integrity. You'll never receive grey-market imports or compounded alternatives from Cured Pharmacy.

Our Clinical Assessment Process

All semaglutide injections are prescription-only medications in the UK, requiring assessment by a qualified prescriber before supply. Our online consultation covers your medical history, current medications, weight management goals, and any contraindications. A UK-registered prescriber reviews your responses within hours, and if clinically appropriate, issues a prescription that our pharmacy team fulfils immediately.

Wegovy Semaglutide Injection: Dosing and Administration

Wegovy is the brand name for semaglutide 2.4mg specifically licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes [3].

The standard Wegovy dosing schedule begins at 0.25mg once weekly for four weeks, then escalates monthly through 0.5mg, 1mg, 1.7mg, and finally to the maintenance dose of 2.4mg. This gradual titration helps your body adapt to the medication and significantly reduces the likelihood of nausea, vomiting, or diarrhoea — the most commonly reported side effects [2][3].

Each pre-filled pen contains a single dose and uses a simple push-button mechanism. You'll inject subcutaneously on the same day each week, rotating injection sites to prevent lipodystrophy. The medication can be taken with or without food, and if you miss a dose by more than five days, clinical guidance recommends resuming at the previous lower dose to avoid gastrointestinal distress.

Expected Results and Timelines

Most patients begin noticing reduced appetite and early weight loss within 4-8 weeks of starting semaglutide, though maximum effects typically occur after reaching the maintenance dose at week 16-20. Clinical trials showed that weight loss continued progressively throughout the 68-week study period, with the greatest reductions occurring between weeks 20 and 60 [1]. Individual results vary based on adherence, dietary modifications, physical activity levels, and metabolic factors.

Semaglutide Injection Price UK: Transparent Costs

At Cured Pharmacy, Wegovy semaglutide injection starts from £79.00 per pen — significantly lower than typical market rates. We guarantee the lowest prices in the UK for genuine, MHRA-licensed weight loss medications, and unlike many providers, we display exact costs before you complete your consultation.

Your final price depends on the prescribed dose and treatment duration determined by your UK prescriber during clinical assessment. There are no hidden consultation fees, subscription charges, or mandatory follow-up costs. You pay only for the medication you need, when you need it.

We accept all major payment methods and offer discreet billing descriptors on your statement. Delivery is included in the medication price, with next-day tracked shipping as standard across mainland UK addresses.

Semaglutide Side Effects and Safety Considerations

The most frequently reported side effects of semaglutide are gastrointestinal: nausea (44% of participants in STEP 1), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects are typically mild to moderate, occur predominantly during dose escalation, and diminish over time as your body adjusts to the medication.

Rare but serious adverse effects include pancreatitis, gallbladder disease, acute kidney injury in the setting of severe dehydration, and hypoglycaemia when used alongside other glucose-lowering medications. Semaglutide carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [2][3].

You should not use semaglutide if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, if you're pregnant or planning pregnancy, or if you have a history of severe gastrointestinal disease. Our UK prescribers screen for these contraindications during your clinical assessment to ensure semaglutide is safe and appropriate for you.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting leading to dehydration, visual changes, or signs of allergic reaction such as rash, swelling, or difficulty breathing. Contact our clinical team at (+44) 116 4646009 if you have concerns about side effects or need dosing guidance between scheduled reviews.

Comparing Semaglutide to Other Weight Loss Treatments

Semaglutide belongs to the GLP-1 receptor agonist class, which also includes liraglutide. Newer dual-pathway medications like tirzepatide activate both GLP-1 and GIP receptors, potentially offering enhanced weight loss in clinical trials [4].

When comparing semaglutide injection to oral weight loss medications, the injectable format delivers superior efficacy. Oral options typically produce modest weight reductions, whilst semaglutide consistently achieves double-digit percentage weight loss in clinical populations [1]. The weekly injection schedule also offers convenience compared to daily tablets, though individual preferences vary.

Your choice of weight loss medication should be guided by your medical history, treatment goals, tolerance for injection versus oral administration, and cost considerations. Our UK prescribers discuss all licensed options during your consultation, recommending the most clinically appropriate treatment based on current NICE guidance and your individual circumstances.

Combining Medication with Lifestyle Changes

Semaglutide is licensed as an adjunct to reduced-calorie diet and increased physical activity, not a standalone solution [3]. Clinical trial participants received intensive behavioural support including dietary counselling and exercise programmes. For optimal results, pair your medication with sustainable nutritional changes, regular physical activity, adequate sleep, and stress management strategies. Our clinical team can provide basic lifestyle guidance and signpost to additional support resources.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle factors.